News

Elenagen™, a novel DNA plasmid therapy that previously demonstrated high clinical benefit and low toxicity in cancer patients, has now shown significant promise in alleviating chronic pain ...
Mice with a version of osteoarthritis experienced symptom relief after expression of a protein targeting a stem-cell receptor ...
Researchers found no significant differences in surgical outcomes or follow-up between housed and unhoused patients with ...
Johnson & Johnson MedTech (NYSE:JNJ) today announced a strategic co-promotion agreement with Pacira BioSciences.
SGLT2 inhibitors, compared with GLP-1 RAs, were associated with lower risks for osteoarthritis and joint replacement surgery among patients with T2D.
CHICO, Calif. - Arthritis is a leading reason for euthanizing older pets, but a new treatment called Synovetin OA is offering hope to pet owners. This breakthrough is promising to change the lives of ...
You’re considering new options for managing chronic pain, and PRP injections might just offer the relief you’re seeking. This innovative therapy taps into your body’s natural healing power, offering ...
Romosozumab, used in osteoporosis treatment, may offer dual benefits by also reducing the risk for osteoarthritis, notably ...
Study in Frontiers in Veterinary Science finds investigational plasmid Elenagen cut osteoarthritis pain by 50 % in dogs and ...
Combining HA with PRP is synergistic, according to a new, well designed, randomized study of knee OA. But…pain relief, no ...
Osteoarthritis (OA) is the most common form of arthritis, affecting over 32 million Americans. According to the World Health ...